Abstract
Purpose
There is limited data available on the safety and efficacy of the second-generation cryoballoon (CB-2) for cryoablation of atrial fibrillation (Cryo-AF). We evaluated the procedural, biophysical, and clinical outcomes of Cryo-AF in a large patient cohort using CB-2 as compared with the first-generation cryoballoon (CB-1).
Methods
Three-hundred and forty consecutive patients undergoing Cryo-AF with CB-1 (n = 140) and CB-2 (n = 200) were retrospectively evaluated.
Results
Paroxysmal AF was more prevalent in CB-1 (86 %) versus CB-2 (72 %) (p = 0.001). During Cryo-AF, the mean balloon temperature was lower with CB-2 at 30 s (8 versus −4 °C; p < 0.001) and 60 s (−26 versus −32 °C; p < 0.001) with equivalent nadir temperatures (both at −50 °C; p = 0.542). With CB-2, time-to-nadir temperature was shorter (232 versus 209 s; p < 0.001) and thaw times were longer (47 versus 53 s; p < 0.001). Acute pulmonary vein (PV) isolation rate was higher with CB-2 (92 versus 98 %; p = 0.036) despite reduced cryoablation time (61 versus 47 min; p < 0.001) and freeze area-under-the-curve (−155,044 versus −116,740 s °C; p < 0.001). With CB-2, procedure time (209 versus 154 min; p < 0.001) and fluoroscopy time (42 versus 27 min; p < 0.001) were shorter, with similar acute/long-term adverse events (AEs) and freedom from AF at 6, 9, and 12 months (89, 86, and 82 %) during 16 ± 8 months of follow-up. However, CB-2 was associated with lower PV reconnection rates at redo ablation (30 versus 13 %; p = 0.037).
Conclusions
With CB-2, acute and long-term PV isolation rates were higher despite shorter ablations, faster balloon cooling, and longer thaw times, with similar AE rates and freedom from AF.
Similar content being viewed by others
References
Packer, D. L., Kowal, R. C., Wheelan, K. R., Cryoablation Investigators, S. T. O. P. A. F., et al. (2013). Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. Journal of the American College of Cardiology, 61(16), 1713–1723.
Namdar, M., Chierchia, G. B., Westra, S., et al. (2012). Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the Cryoballoon. Europace, 14(2), 197–203.
Van Belle, Y., Janse, P., Theuns, D., Szili-Torok, T., & Jordaens, L. (2008). One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace, 10(11), 1271–1276.
Klein, G., Oswald, H., Gardiwal, A., et al. (2008). Efficacy of pulmonary vein isolation by cryoballoon ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm, 5(6), 802–806.
Neumann, T., Vogt, J., Schumacher, B., et al. (2008). Circumferential pulmonary vein isolation with the cryoballoon technique: results from a prospective 3-center study. Journal of the American College of Cardiology, 52(4), 273–278.
Fürnkranz, A., Chun, K. R., Nuyens, D., et al. (2010). Characterization of conduction recovery after pulmonary vein isolation using the “single big cryoballoon” technique. Heart Rhythm, 7(2), 184–190.
Fürnkranz, A., Bordignon, S., Schmidt, B., et al. (2013). Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. Journal of Cardiovascular Electrophysiology, 24(5), 492–497.
Casado-Arroyo, R., Chierchia, G. B., Conte, G., et al. (2013). Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon. Heart Rhythm, 10(9), 1318–1324.
Fürnkranz, A., Bordignon, S., Schmidt, B., et al. (2013). Luminal esophageal temperature predicts esophageal lesions after second-generation cryoballoon pulmonary vein isolation. Heart Rhythm, 10(6), 789–793.
Metzner, A., Burchard, A., Wohlmuth, P., et al. (2013). Increased incidence of esophageal thermal lesions using the second-generation 28 mm cryoballoon. Circulation. Arrhythmia and Electrophysiology, 6(4), 769–775.
Lim, H. W., Cogert, G. A., Cameron, C. S., Cheng, V. Y., Sandler, D. A. (2014). Atrioesophageal fistula during cryoballoon ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 25(2), 208–213.
Andrade, J. G., Dubuc, M., Guerra, P. G., et al. (2013). Pulmonary vein isolation using a second-generation cryoballoon catheter: a randomized comparison of ablation duration and method of deflation. Journal of Cardiovascular Electrophysiology, 24(6), 692–698.
Chierchia, G. B., Di Giovanni, G., Sieira-Moret, J., et al. (2014). Initial experience of three-minute freeze cycles using the second-generation cryoballoon ablation: acute and short-term procedural outcomes. Journal of Interventional Cardiac Electrophysiology, 39(2), 145–151.
Fürnkranz, A., Bordignon, S., Dugo, D., et al. (2014). Improved one-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. Journal of Cardiovascular Electrophysiology, 25(8), 840–844.
Giovanni, G. D., Wauters, K., Chierchia, G. B., et al. (2014). One-year follow-up after single procedure cryoballoon ablation: a comparison between the first and second generation balloon. Journal of Cardiovascular Electrophysiology, 25(8), 834-839.
Chinitz, J. S., Kulina, R. A., Gangireddy, S. R., et al. (2013). Objective quality assessment of atrial fibrillation ablation: a novel scoring system. Heart Rhythm, 10(7), 1074–1079.
Chun, K. R., Schmidt, B., Metzner, A., et al. (2009). The ‘single big cryoballoon’ technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. European Heart Journal, 30(6), 699–709.
Ciconte, G., Chierchia, G. B., de Asmundis, C., et al. (2014). Spontaneous and adenosine-induced pulmonary vein reconnection after cryoballoon ablation with the second generation device. Journal of Cardiovascular Electrophysiology, 25(8), 848–851.
Knecht, S., Kühne, M., Osswald, S., Sticherling, C., et al. (2014). Quantitative assessment of a second-generation cryoballoon ablation catheter with new cooling technology—a perspective on potential implications on outcome. Journal of Cardiovascular Electrophysiology, 40(1), 17–21.
Metzner, A., Reissmann, B., Rausch, P., et al. (2014). One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circulation. Arrhythmia and Electrophysiology, 7(2), 288–292.
Chierchia, G. B., Di Giovanni, G., Ciconte, G., et al. (2014). Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up. Europace, 16(5), 639–644.
Bordignon, S., Fürnkranz, A., Dugo, D., et al. (2014). Improved lesion formation using the novel 28 mm cryoballoon in atrial fibrillation ablation: analysis of biomarker release. Europace, 16(7), 987–993.
Metzner, A., Rausch, P., Lemes, C., et al. (2014). The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. Journal of Cardiovascular Electrophysiology, 25(5), 466–470.
Gage, A. A., & Baust, J. (1998). Mechanisms of tissue injury in cryosurgery. Cryobiology, 37(3), 171–186.
Ghosh, J., Martin, A., Keech, A. C., et al. (2013). Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation. Heart Rhythm, 10(9), 1311–1317.
Conflict of interest
H. Lim and R. Sara are employees of Medtronic, Inc., the manufacturer of the cryoballoons evaluated in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aryana, A., Morkoch, S., Bailey, S. et al. Acute procedural and cryoballoon characteristics from cryoablation of atrial fibrillation using the first- and second-generation cryoballoon: a retrospective comparative study with follow-up outcomes. J Interv Card Electrophysiol 41, 177–186 (2014). https://doi.org/10.1007/s10840-014-9942-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-014-9942-7